In Vitro Synergy of Colistin in Combination with Meropenem or Tigecycline against Carbapenem-Resistant Acinetobacter baumannii

Acinetobacter baumannii is currently classified as one of six pathogens that contribute to increased patient mortality. Thus, exploratory studies navigating alternative treatment strategies are of supreme interest. Herein, we completed minimum inhibitory concentration (MIC) testing, and time-kill an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Antibiotics (Basel)
Hauptverfasser: Abdul-Mutakabbir, Jacinda C., Yim, Juwon, Nguyen, Logan, Maassen, Philip T., Stamper, Kyle, Shiekh, Zain, Kebriaei, Razieh, Shields, Ryan K., Castanheira, Mariana, Kaye, Keith S., Rybak, Michael J.
Format: Artigo
Sprache:Inglês
Veröffentlicht: MDPI 2021
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8300792/
https://ncbi.nlm.nih.gov/pubmed/34356801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics10070880
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge